Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Oncotarget|July 26, 2018
Correction: MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastomaSaurabh Agarwal, Giorgio Milazzo, Kimal Rajapakshe, et al.
Cancer Research|February 28, 2002
Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastomaJason M Shohet, M John Hicks, Sharon E Plon, et al.
Plos One|February 7, 2015
WIP1 phosphatase as a potential therapeutic target in neuroblastomaMark Richter, Tajhal Dayaram, Aidan G Gilmartin, et al.
Plos One|December 19, 2013
A p53 drug response signature identifies prognostic genes in high-risk neuroblastomaEveline Barbieri, Katleen De Preter, Mario Capasso, et al.
Molecular Cancer Therapeutics|May 18, 2005
Anti-gene peptide nucleic acid specifically inhibits MYCN expression in human neuroblastoma cells leading to cell growth inhibition and apoptosisRoberto Tonelli, Stefania Purgato, Consuelo Camerin, et al.
Angiogenesis|April 13, 2011
Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastomaDanielle M Patterson, Dongbing Gao, Denae N Trahan, et al.
Cancer Research|December 17, 2013
Histone chaperone CHAF1A inhibits differentiation and promotes aggressive neuroblastomaEveline Barbieri, Katleen De Preter, Mario Capasso, et al.
Cancer Research|April 19, 2011
A genome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastomaJason M Shohet, Rajib Ghosh, Cristian Coarfa, et al.
Pediatric Blood & Cancer|July 31, 2020
Is high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factorsSarah B Whittle, Valeria Smith, Allison Silverstein, et al.
Cancer Research|May 21, 2013
G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenicDanielle M Hsu, Saurabh Agarwal, Ashley Benham, et al.
Pageof 4